Name

Volasertib

Alternate Names

BI 6727

Abbreviations

None

Category

Chemotherapy

Subcategory

PLK Inhibitor

NSC Number

None

Primary Site

AML trials
Ovarian trials
Solid tumors trials

Histology

None

Remarks

As of 1/1/2013, in multiple clinical trials (both phase I and II) for AML, ovarian tumors and solid tumors. Volasertib is the second in a novel class of drugs call dihydropteridinone derivatives.

Coding

This drug should be coded
Glossary